SAN FRANCISCO — An in-depth analysis of renal and safety data from the landmark Dapagliflozin Effect on Cardiovascular Events (DECLARE-TIMI 58) study of the sodium-glucose cotransporter type 2 (SGLT2) ...

MIAMI – An investigational formulation of allopregnanolone, a metabolite of progesterone, in which dosing replicates soaring levels of the hormone that occur during the height of pregnancy, appears to ...

Alto Neuroscience Highlights Peer-Reviewed Publication of PAX-D Study in The Lancet Psychiatry Demonstrating Robust Clinical Effects of Pramipexole for Patients with Treatment-Resistant Depression – ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exo Therapeutics, Inc., a pre-clinical company developing a pipeline of drug candidates that target exosites, unique small-molecule binding pockets that are distinct ...

Researchers at Hiroshima University have developed a realistic, highly sensitive method to detect the Unruh effect—a ...

– Compelling PAX-D results guided Alto’s acquisition of ALTO-207, designed to induce rapid antidepressant effects while mitigating dose-limiting adverse events of pramipexole – – Alto plans to ...